Coronavirus, COVID-19, SARS-CoV-2, Spike glycoproteins, Longer interval mRNA vaccine regimen, CD4 T cell, CD8 T cell, CD4 T cell help, B cells, humoral responses, AIM assay, immunological memory
SARS-CoV-2, COVID-19, nanoluciferase, bioluminescence imaging, neutralizing antibodies, convalescent patients, human ACE2 transgenic mice, monocytes, natural killer cells, monocytes, pathogenesis, inflammatory cytokines, Fc effector functions
SARS-CoV-2, mRNA vaccine, dose interval, B cells, CD4+ T cells, CD8+ T cells, phenotype